P&G closes diagnostics deal
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble and Inverness Medical Innovations complete a previously announced deal to create SPD Swiss Precision Diagnostics, a 50/50 joint venture business that develops, manufactures and markets diagnostic products, the firms announce May 17. The new company is headquartered in Geneva and will be the world's leading provider of home pregnancy test and fertility/ovulation monitoring products with brands including Clearblue and Fact Plus, say the firms, which outlined plans for the partnership in January (1"The Tan Sheet" Jan. 1, 2007, p. 10)...
You may also be interested in...
P&G Moves Into Consumer Diagnostics With Inverness Joint Venture
Procter & Gamble enters the consumer diagnostic products business with an agreement to form a 50/50 joint venture with Waltham, Mass.-based Inverness Medical Innovations
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.